RxDoctor Payments Data

Farlyn Charlot-Wadley

Foot Surgery · New Haven, CTNPI 1538339080

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,402 of the $4,377 with a category attached, or 77.7%. 20 manufacturers reported payments, led by Smith+Nephew at 31.8% of the total. Reporting peaked in 2021 at $1,326 and has fallen 59.7% since, to $534 in 2025. Among foot surgery clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,377in general payments, 2019–2025

Across 45 payments — averaging $97.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$1K
  • Gramercy Extremity Orthopedics LLC$1K
  • Organogenesis Inc.$219
  • Gotham Surgical Solutions & Devices, Inc.$144
  • Medtronic$138
  • Polynovo North America LLC$138
  • plus $1K from 14 others

What the payments were for

  • Consulting fees$97522%
  • Food & beverage$3,40278%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,377 in reported general payments places this provider in the 95th percentile of 20 foot surgery providers in Connecticut.

See all foot surgery providers in Connecticut

Medicare billing

Part B allowed, 2024
$51,360
Medicare patients
199
Services billed
622

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox77$3,038
CiclopiroxCiclopirox Olamine61$1,697
Ammonium Lactate38$738
Pregabalin21$661
Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort14$602
Diclofenac Sodium18$444
Fluconazole20$314
Clotrimazole24$298
Mupirocin25$199
Ketoconazole20$193
Cefadroxil20$140

Paid to pharmacies, not to this prescriber.

Other foot surgery in New Haven

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →